(Q38067203)

28 August 2017

1 reference

title

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease (English)

1 reference

28 August 2017

1 reference

1 reference

Anders Björklund

4

0 references

Roger A. Barker

object named as

Roger A Barker

series ordinal

1

0 references

author name string

Jessica Barrett

series ordinal

2

1 reference

28 August 2017

Sarah L Mason

series ordinal

3

1 reference

28 August 2017

publication date

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

12

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

84-91

1 reference

Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Functional reactivation of the deafferented neostriatum by nigral transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. Clinica Puerta de Hierro Neural Transplantation Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Spheramine for treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Maladaptive striatal plasticity in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Molecular mechanisms of l-DOPA-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Research in motion: the enigma of Parkinson's disease pathology spread

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Are synucleinopathies prion-like disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Patients Beware: Commercialized Stem Cell Treatments on the Web

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970295-8

7 January 2021

10.1016/S1474-4422(12)70295-8

Identifiers

DOI

1 reference

28 August 2017

1 reference